Bixiye
QP31R1-20 Update: Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Natiijooyinka Raadinta
Soo bandhiga 1971 - 1980 ee natiijooyinka 4296
Bixiye
QP54-20 MHCP Pharmacy Benefit Update — Pharmacy Benefit Exclusion for Nexplanon® and Trodelvy™
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP57-20 Commercial Pharmacy Benefit Update: Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP53-20 Commercial Pharmacy Benefit Exclusion for Nexplanon®
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP56-20 U.S. Department of Health and Human Services Announced Additional Opportunity for Funding
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP49-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema (HAE)
Taariikhda wax ku ool ah ee barnaamijka: Jun 10, 2020
Bixiye
QP50-20 Enforcement of Timely Filing for Minnesota Health Care Programs Claims
Taariikhda wax ku ool ah ee barnaamijka: Jun 10, 2020
Bixiye
QP48-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Obeticholic acid
Taariikhda wax ku ool ah ee barnaamijka: Jun 10, 2020
Bixiye
QP51-20 Member Mobile App for Drug and Medical Cost Estimator
Taariikhda wax ku ool ah ee barnaamijka: Jun 10, 2020
Faa'iidooyinka & Caymiska
Care Coordinator Services